skip to main
|
skip to sidebar
Drug Discovery with Quantum Pharmaceuticals
Wednesday, December 2, 2009
The Blog has moved
to another location. The blog feed is now merged with the Quantum Pharmaceuticals official site
http://q-pharm.com
. See you there!
Newer Posts
Older Posts
Home
Subscribe to:
Posts (Atom)
Quantum publications
Subscribe to Drug Discovery with Quantum Pharmaceuticals by Email
FeedBurner FeedCount
Labels
IC50
(17)
docking
(11)
collaboration
(10)
water
(9)
polar liquid
(8)
HERG
(6)
Quantum Software
(6)
publications
(5)
solvation energy
(5)
ADME
(4)
Generalized Born
(4)
toxicity
(4)
absorbtion
(3)
antiviral
(3)
bioavailability
(3)
false postive
(3)
HIV
(2)
MRDD
(2)
active transport
(2)
oncology
(2)
openbabel
(2)
talk
(2)
trombine
(2)
COPD
(1)
GPCR
(1)
HIV-1 integrase
(1)
HSV
(1)
LD50
(1)
PDK1
(1)
QSAR
(1)
albumin
(1)
cancer
(1)
cardiotoxicity
(1)
drug discovery platform
(1)
druglikeness
(1)
human neutrophil elastase
(1)
inflammation
(1)
kinase
(1)
logP
(1)
mechanism of action exploration
(1)
new therapeutic uses
(1)
q-Mol
(1)
scoring
(1)
selectivity
(1)
ss DNA
(1)
About Quantum Pharmaceuticals
Business Development
Peter Fedichev (Quantum CTO)
Quantum Pharmaceuticals Suggested Links
Quantum Pharmaceuticals' Products pages and Demo
Official Quantum Pharmaceuticals Website
Blog Archive
▼
2009
(8)
▼
December
(1)
The Blog has moved
►
August
(1)
►
June
(1)
►
April
(1)
►
March
(1)
►
January
(3)
►
2008
(27)
►
December
(2)
►
November
(2)
►
October
(4)
►
September
(5)
►
August
(2)
►
June
(3)
►
May
(3)
►
April
(1)
►
March
(1)
►
January
(4)
►
2007
(11)
►
December
(4)
►
September
(2)
►
August
(1)
►
May
(1)
►
April
(1)
►
January
(2)
►
2006
(3)
►
December
(1)
►
October
(1)
►
June
(1)